Nick Ng Zhi Peng

Dr. Nick Ng Zhi Peng

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2010 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
MCMin-Hoe Chew
Min-Hoe Chew
SYShen-Ann Eugene Yeo
Shen-Ann Eugene Yeo
NPNick Ng Zhi Peng
Nick Ng Zhi Peng
KLKiat-Hon Lim
Kiat-Hon Lim
PKPoh-Koon Koh
Poh-Koon Koh
KEKong-Weng Eu
Kong-Weng Eu

13 April 2011 in Asia Pacific Journal of Public Health
Verified
Journal Article
Closed access
AFAaron Foo
Aaron Foo
JTJoshua J. P. Thia
Joshua J. P. Thia
NPNick Ng Zhi Peng
Nick Ng Zhi Peng
NFNgan Phoon Fong
Ngan Phoon Fong
GKGerald Choon-Huat Koh
Gerald Choon-Huat Koh
To assess the awareness and acceptability of colorectal cancer (CRC) screening in noncompliant Singaporeans and to determine if their barriers can be overcome by education. A questionnaire developed from thematic analysis of open-ended interviews with 72 subjects was administered to 580 residents in a local high-rise housing estate. Participants aware of CRC screening were assessed for barriers and acceptability of CRC screening. All participants were subsequently educated about CRC screening and reassessed for barriers and acceptance. Those keen for fecal occult blood testing (FOBT) were offered FOBT kits and followed up. CRC screening awareness was poor. Having no symptoms was the most common barrier. More barriers to FOBT than to colonoscopy were reduced with education. After education, acceptability toward FOBT increased but rejection rates rose even higher. FOBT is probably Singapore’s most acceptable screening modality. Education is limited by barriers, which need to be overcome by alternative measures.

1 January 2019 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
WLWei-Liang Loh
Wei-Liang Loh
NPNick Ng Zhi Peng
Nick Ng Zhi Peng
TKTousif Kabir
Tousif Kabir
CCChung Yip Chan
Chung Yip Chan
Introduction: Gallstone(s) impacted at the distal small bowel causing intestinal obstruction as a result of cholecystoenteric fistula is a well-known, albeit uncommon surgical condition. The rare Bouveret's Syndrome, which refers to the proximal impaction of gallstone(s) in the duodenum or pylorus resulting in the gastric outlet obstruction (GOO), has also been described in the literature. However, gallbladder mucocele with extrinsic compression of the duodenum and/or pylorus causing GOO is a separate entity that is extremely rare. Presentation of case: A patient who presented with loss of appetite and weight, with intermittent vomiting over a course of eight months was found to have GOO secondary to extrinsic duodenal compression from a large gallbladder mucocele. Surgical intervention in the form of cholecystectomy was performed, and the patient's symptoms resolved post-operatively. Discussion: We describe an extremely rare case of GOO, which can be easily corrected with cholecystectomy. Removal of the gallbladder removes the root cause of the issue, and should be first line therapy unless the patient is unfit for surgery. Conclusion: This extremely rare cause of GOO should be recognized, and treated promptly with surgery if possible. Highlights:

29 August 2018 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
WTW. J. Tan
W. J. Tan
NPNick Ng Zhi Peng
Nick Ng Zhi Peng
YCY. D. Chen
Y. D. Chen
YCY. H. M. Chee
Y. H. M. Chee
FFFung Joon Foo
Fung Joon Foo
MCM. H. Chew
M. H. Chew
Synchronous polypectomy in colonic malignancies is contentious due to the perceived risks of tumour implantation at polypectomy sites (PS). We assess the risks of tumour implantation after synchronous polypectomy. An analysis of all endoscopies for cancer that were accompanied by synchronous polypectomies from 2005 to 2009 was performed. The incidence of metachronous colorectal cancers located at the same segment of a previous PS was the surrogate for tumour implantation. Data on patient demographics, tumour and polyp location(s) and follow-up outcomes were extracted. The rate of metachronous lesions at the same segment of a previous PS between patients who had all synchronous PS resected (Group A) and patients with PS left in-situ (Group B) were compared. Two hundred and eighty-four patients had synchronous polypectomy performed during their initial endoscopy for cancer. Three patients were lost to follow-up and, in the remaining 281 patients, 87 (31.0%) were in Group A while 194 (69%) were in Group B. Median age, gender, tumour location, tumour stage, and pathological characteristics were similar between both groups. 2 (0.7%) patients developed local recurrences. Six (2.1%) patients developed metachronous lesions, four of which were located at the same segment where synchronous polypectomy was previously performed. The rates of metachronous lesions at the PS in groups A and B were similar at 1.1% (1/87) and 1.5% (3/194), respectively (p = 0.795). Malignant implantation after synchronous polypectomy in the setting of a newly diagnosed cancer remains unproven. Even if tumor implantation did occur, the incidence is likely low.

1 January 2017 in EJVES Short Reports
Verified
Journal Article
Open access
NPNick Ng Zhi Peng
Nick Ng Zhi Peng
TCTze Tec Chong
Tze Tec Chong
While hypertension, pericardial, myocardial, and coronary artery disease are common cardiovascular manifestations of systemic lupus erythematosus (SLE), aortic aneurysms (AA) are rare but increasingly diagnosed, with the true incidence unknown. A 40 year old female suffering from SLE with a 5.3 cm saccular eccentric infrarenal abdominal aortic aneurysm (AAA) was treated successfully with endovascular aneurysm repair (EVAR) using the Medtronic Endurant II bifurcated stent graft and followed up 2 years post-operatively. Pre-operatively, open and EVAR options were offered and the latter was chosen by the patient. Proposed mechanisms for AA formation in SLE including accelerated atherosclerosis brought about by chronic steroid use and SLE associated vasculitis and cystic medial degeneration (CMD) have been discussed in other case reports and series. To the authors' knowledge, the use of EVAR for AAA in SLE patients has not been reported in available literature. The need for earlier repair, screening, and detection as well as the long-term suitability, durability, and surveillance of EVAR remain unknown. The benefit of using the Ovation device in minimising late neck dilatation is also discussed. EVAR was demonstrated to be a suitable form of repair in a young female patient with SLE and AAA, followed up 2 years post-surgery. The ideal repair and the natural history of these aneurysms remains to be studied.

21 February 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
MLMarco Lizwan
Marco Lizwan
HYHao Yun Yap
Hao Yun Yap
JCJack Kian Ch’ng
Jack Kian Ch’ng
TCTze Tec Chong
Tze Tec Chong
NPNick Ng Zhi Peng
Nick Ng Zhi Peng
Background: Endovascular therapy for lower-limb arterial disease is widely performed today. A vast array of sheaths, catheters, wires, balloon types, stents, and tools such as atherectomy, thrombectomy, and lithotripsy devices are now available to achieve the best outcomes in terms of vessel patency and ultimately limb salvage. The use of atherectomy devices, however, has raised some controversies in terms of outcome efficacy, cost effectiveness, and safety profile in various series and studies. Objectively, the types and disease pattern in these studies are also greatly heterogeneous. Methods: Here, we reported three cases which exemplify how these atherectomy devices have served as a valuable tool, especially for patients with complex and heavily calcified lesions. Results: The three cases highlighted scenarios where atherectomy displayed good outcomes, each involving the use of atherectomy devices to treat highly calcified vessels. Conclusions: Despite the concerns with atherectomy devices, we believe that with proper selection, patients will benefit most from their ability to achieve the best outcomes of both vessel patency and limb salvage.